Retinol binding protein 4 and incident diabetes - the atherosclerosis risk in communities study (ARIC study);Proteína carreadora de retinol 4 e diabetes incidente - atherosclerosis risk in communities study (ARIC study)

Revista Brasileira de Epidemiologia

Volumn 16, Issue 2, 2013, Pages 388-397

  Luft, Vivian C ^a   Pereira, Mark ^b   Pankow, James S ^b   Ballantyne, Christie ^c   Couper, David ^d   Heiss, Gerardo ^d   Duncan, Bruce B ^a,d  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b UNIVERSITY OF MINNESOTA   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d University of North Carolina at Chapel Hill   (United States)

Author keywords

Diabetes; Epidemiologic studies; Human; RBP4 protein; Retinol binding proteins

Indexed keywords

PLASMA RETINOL BINDING PROTEIN; RBP4 PROTEIN, HUMAN;

AFRICAN AMERICAN; ARTICLE; ATHEROSCLEROSIS; BLOOD; CAUCASIAN; COHORT ANALYSIS; DIET RESTRICTION; FEMALE; HUMAN; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PREDICTIVE VALUE; RISK ASSESSMENT; TIME;

AFRICAN AMERICANS; ATHEROSCLEROSIS; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; EUROPEAN CONTINENTAL ANCESTRY GROUP; FASTING; FEMALE; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RETINOL-BINDING PROTEINS, PLASMA; RISK ASSESSMENT; TIME FACTORS;

EID: 84885398967     PISSN: 1415790X     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1415-790X2013000200014     Document Type: Article

References (24)

1. International Diabetes Federation. Diabetes atlas. Brussels: International Diabetes Federation; 2009.
2. World Health Organization. Preventing chronic diseases: a vital investment. Geneva; 2005.
3. Yang Q, Graham TE, Mody N, Preitner F, Peroni OD, Zabolotny JM et al. Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature 2005; 436: 356-62.
4. Graham TE, Yang Q, Bluher M, Hammarstedt A, Ciaraldi TP, Henry RR et al. Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. N Engl J Med 2006; 354: 2552-63.
5. Chiefari E, Paonessa F, Iiritano S, Le Pera I, Palmieri D, Brunetti G et al. The cAMP-HMGA1-RBP4 system: a novel biochemical pathway for modulating glucose homeostasis. BMC Biol 2009; 7: 24.
6. Henze A, Frey SK, Raila J, Tepel M, Scholze A, Pfeiffer AF et al. Evidence that kidney function but not type 2 diabetes determines retinol-binding protein 4 serum levels. Diabetes 2008; 57: 3323-6.
7. Janke J, Engeli S, Boschmann M, Adams F, Böhnke J, Luft FC, et al. Retinol-binding protein 4 in human obesity. Diabetes 2006; 55: 2805-10.
8. Duncan BB, Schmidt MI, Pankow JS, Ballantyne CM, Couper D, Vigo A et al. Atherosclerosis Risk in Communities Study. Low-grade systemic inflammation and the development of type 2 diabetes: the atherosclerosis risk in communities study. Diabetes 2003; 52: 1799-805.
9. Duncan BB, Schmidt MI, Pankow J, Bang H, Couper D, Ballantyne CM et al. Adiponectin and the developmen.t of type 2 diabetes - the ARIC Study. Diabetes 2004; 53: 2473-8.
10. Schmidt MI, Duncan BB, Vigo A, Pankow JS, Couper D, Ballantyne CM et al. Leptin and incident type 2 diabetes: risk or protection? Diabetologia 2006; 49: 2086-96.
11. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150: 604-12.
12. Collett D. Modelling survival data in medical research. London: Chapman & Hall; 1994.
13. Graham TE, Kahn BB. Tissue-specific alterations of glucose transport and molecular mechanisms of intertissue communication in obesity and type 2 diabetes. Horm Metab Res 2007; 39: 717-21.
14. Tamori Y, Sakaue H, Kasuga M. RBP4, an unexpected adipokine. Nat Med 2006; 12: 30-1.
15. Broch M, Vendrell J, Ricart W, Richart C, Fernandez- Real JM. Circulating retinol-binding protein-4, insulin sensitivity, insulin secretion, and insulin disposition index in obese and nonobese subjects. Diabetes Care 2007; 30: 1802-6.
16. Stefan N, Hennige AM, Staiger H, Schleicher E, Fritsche A, Haring HU. Circulating retinol-binding protein-4, insulin sensitivity, insulin secretion, and insulin disposition index in obese and nonobese subjects: response to Broch et al. Diabetes Care 2007; 30: e91.
17. Fernandez-Real JM, Vendrell J, Ricart W, Richart C, Broch M. Circulating retinol-binding protein-4, insulin sensitivity, insulin secretion, and insulin disposition index in obese and nonobese subjects: response to Stefan et al. Diabetes Care 2007; 30: e92.
18. Cho YM, Youn BS, Lee H, Lee N, Min SS, Kwak SH et al. Plasma retinol-binding protein-4 concentrations are elevated in human subjects with impaired glucose tolerance and type 2 diabetes. Diabetes Care 2006; 29: 2457-61.
19. Jia W, Wu H, Bao Y, Wang C, Lu J, Zhu J et al. Association of serum retinol-binding protein 4 and visceral adiposity in chinese subjects with and without type 2 diabetes. J Clin Endocrinol Metab 2007; 92: 3224-9.
20. Lewis JG, Shand BI, Elder PA, Scott RS. Plasma retinol-binding protein is unlikely to be a useful marker of insulin resistance. Diabetes Res Clin Pract 2008; 80: 13-5.
21. Basu R, la Man C, Campioni M, Basu A, Klee G, Toffolo G et al. Effects of age and sex on postprandial glucose metabolism: differences in glucose turnover, insulin secretion, insulin action, and hepatic insulin extraction. Diabetes 2006; 55: 2001-4.
22. Makimura H, Wei J, Dolan-Looby SE, Ricchiuti V, Grinspoon S. Retinol-binding protein levels are increased in association with gonadotropin levels in healthy women. Metabolism 2009; 58: 479-87.
23. Ciardi C, Tatarczyk T, Tschoner A, Kranebitter M, Niederwanger A, Ebenbichler CF et al. Effect of postprandial lipemia on plasma concentrations of A-FABP, RBP-4 and visfatin. Nutr Metab Cardiovasc Dis 2009. doi:10.1016/j.numecd.2009.05.013.
24. Ribel-Madsen R, Friedrichsen M, Vaag A, Poulsen P. Retinol-binding protein 4 in twins: regulatory mechanisms and impact of circulating and tissue expression levels on insulin secretion and action. Diabetes 2010; 20: 662-8.